PARIS & CAMBRIDGE, Mass.--(BUSINESS WIRE)--Eyevensys, a privately held, clinical-stage biotechnology company developing non-viral gene therapies for ophthalmic diseases, today announced it has been ...
PARIS--(BUSINESS WIRE)--TISSIUM, a privately-owned medtech company developing biomorphic programmable polymers for tissue reconstruction, announced today it has been nominated in the French Tech 120 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback